Advertisement

Topics

Novus Therapeutics Reports Third Quarter 2017 Results

17:11 EST 8 Nov 2017 | FinanzNachrichten

IRVINE, California, Nov. 8, 2017 /PRNewswire/ -- Novus Therapeutics, Inc. (NASDAQ: NVUS), a development stage specialty pharmaceutical company focused on the development of products for disorders ...

Original Article: Novus Therapeutics Reports Third Quarter 2017 Results

NEXT ARTICLE

More From BioPortfolio on "Novus Therapeutics Reports Third Quarter 2017 Results"

Advertisement
Quick Search
Advertisement
Advertisement